Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

A recent study revealed that bevacizumab (Avastin) provides survival benefits in patients with colorectal cancer (CRC) for ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

The pharmaceutical giant said for 2025 it anticipates sales growth in the mid-single-digit range at constant exchange rates, ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the condition. Sometimes, the better option might be surgery, corrective wear, or ...

The benefits of bevacizumab (Avastin) for the treatment of patients with colorectal cancer (CRC) appear to persist for ...

HK inno.N will handle domestic marketing and sales of the targeted cancer drug "Avastin" from global pharmaceutical company Roche for colorectal and gynecological cancers. HK inno.N noted on the ...

Koh Young Technology gains FDA approval for medical robot in brain surgery Koh Young Technology secures FDA clearance for innovative robotic system in neurosurgery ...

For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing. We’ve issued final ...